Ann Cunningham – Biography
Last update: May 19, 2026Executive profile
Ann was Managing Partner at i3 Strategy Partners, and Vice President, Neurodegenerative Disease and Psychiatry at Teva Pharmaceutical Industries. Ann Cunningham joined VistaGen Therapeutics in 2026.
Ann Cunningham is currentlyDirector at VistaGen Therapeutics - View - VistaGen Therapeutics org chart
Independent Non Executive Director at Alterity Therapeutics - View - Alterity Therapeutics org chart
Create your alert
to follow the career of Ann Cunningham.
Education
Ann Cunningham has a Bachelor of Arts in Psychology from Yale University in 1990 and a Master of Business Administration from University of Michigan - Stephen M. Ross School of Business in 1996.
They have also studied at Yale University :
Find more alumni from Yale University
They have also studied at University of Michigan - Stephen M. Ross School of Business :
Find more alumni from University of Michigan - Stephen M. Ross School of Business
More about Ann Cunningham
Selected links
Do you need to know more about Ann Cunningham? More results.
Participate
Social media
- Ann Cunningham on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Ann Cunningham
The colleagues of Ann Cunningham
Company Colleagues
- At VistaGen Therapeutics, Ann Cunningham has 24 colleagues including Shawn Singh (CEO & Director), Mary Rotunno (Director)…
- At Alterity Therapeutics, Ann Cunningham has 9 colleagues including David Stamler (CEO), Lawrence Gozlan (Director)…
Homonyms
- Ann Cunningham - Manager of Health, Safety, Environment and Logistic - Semefab
Industry Colleagues
- In the Biotechnology industry, Ann Cunningham has 35,926 colleagues in 2,426 companies located in 45 countries. 16,995 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Ann Cunningham.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Ann Cunningham.
